Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin.
about
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I studyThe influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartanFimasartan: A New Angiotensin Receptor Blocker.Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.Renal Drug Transporters and Drug Interactions.Disposition pathway-dependent approach for predicting organic anion-transporting polypeptide-mediated drug-drug interactions.24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.Validated LC-MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies.Glucuronidation of fimasartan, a new angiotensin receptor antagonist, is mainly mediated by UGT1A3Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
P2860
Q34353787-6F8C4D4E-8169-4AA7-A525-3669AA75030CQ34677197-A23CBE1C-4BC8-4463-B876-38AD090E6F5BQ38858118-3C3E9440-7351-4733-BC63-8F6231810573Q38888365-2EB0C6B6-B2CB-406B-BF44-9406D3F6E3D1Q39140289-D34706F0-EC6E-4206-A173-2A552CD82395Q39451287-8C1E3875-85CD-4C90-BD18-61E5651438CCQ47430437-7587D8CE-362B-4E62-9D44-C542C7EBD7C1Q50591321-10B30035-7D69-4712-A7F2-D07786B93B09Q57148214-76207A27-B057-4C6C-A82A-82E5CECE6801Q59126269-1ADD491C-301E-4A93-A7DD-88CABFCD4555
P2860
Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@en
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@nl
type
label
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@en
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@nl
prefLabel
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@en
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@nl
P2093
P2860
P356
P1476
Increased systemic exposure of ...... y ketoconazole and rifampicin.
@en
P2093
Im-Sook Song
In-Jin Jang
Joo-Youn Cho
Jung Won Kim
Kyoung Soo Lim
Kyung-Sang Yu
Sang-Goo Shin
Seo Hyun Yoon
SoJeong Yi
Tae-Eun Kim
P2860
P356
10.1177/0091270011433328
P50
P577
2013-01-24T00:00:00Z